• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于甲状腺肿瘤风险分层的新评分系统。

A new scoring system for risk stratification of thyroid tumors.

作者信息

Yuan Ya, Shu Hua, Li Lu, Wu Liuxi, Yu Fei

机构信息

Department of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province, 210029, China.

Department of Ultrasound, Nanjing Drum Tower Hospital, Nanjing, Jiangsu Province, 210000, China.

出版信息

BMC Med Imaging. 2025 Apr 10;25(1):114. doi: 10.1186/s12880-025-01633-0.

DOI:10.1186/s12880-025-01633-0
PMID:40211196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11983903/
Abstract

OBJECTIVES

To develop an ultrasound feature-based risk stratification system for differentiating benign, low-risk and malignant thyroid tumors and compare it with existing TI-RADS.

METHODS

The retrospective study included patients who underwent preoperative neck ultrasound examination from January 2018 to June 2023, and their ultrasound characteristics were recorded. According to surgical pathological findings, they were classified into three categories: benign, low-risk, and malignant. Univariable and multivariable logistic regression analyses were used to assess the association of qualitative ultrasound features with different risk stratifications and a new scoring system was established to evaluate its diagnostic efficacy, and to compare it with TI-RADS.

RESULTS

Aspect ratio ≥1 was an independent risk factor in the comparison of benign and low-risk thyroid nodules, and in the comparison of benign and malignant nodules, hypoechoic,irregular margin,nodule max diameter ≤1 cm,the aspect ratio ≥1 and elasticity score ≥3 were independent risk factors. According to the multivariate analysis, they were assigned 1, 2, 2, 3, 2/4 points respectively, and we established a new scoring system. According to ROC analysis, the total score of 0-4.5 was considered as benign nodules, 4.5-5.5 was considered as low-risk nodules, and more than 5.5 were considered as malignant nodules. Compared it to ACR-TI-RADS, this scoring system performed better than in differentiating benign and malignant nodules (P = 0.001, P = 0.018, respectively).

CONCLUSION

The scoring system based on ultrasound features established in this study can be used for risk stratification of thyroid nodules more efficiently, it has higher sensitivity and specificity for the differentiation of benign and malignant nodules.

摘要

目的

开发一种基于超声特征的风险分层系统,用于区分良性、低风险和恶性甲状腺肿瘤,并将其与现有的甲状腺影像报告和数据系统(TI-RADS)进行比较。

方法

这项回顾性研究纳入了2018年1月至2023年6月接受术前颈部超声检查的患者,并记录了他们的超声特征。根据手术病理结果,将他们分为三类:良性、低风险和恶性。采用单变量和多变量逻辑回归分析来评估定性超声特征与不同风险分层之间的关联,并建立一个新的评分系统来评估其诊断效能,并与TI-RADS进行比较。

结果

在良性与低风险甲状腺结节的比较中,纵横比≥1是独立危险因素;在良性与恶性结节的比较中,低回声、边界不规则、结节最大直径≤1 cm、纵横比≥1和弹性评分≥3是独立危险因素。根据多变量分析,分别赋予它们1、2、2、3、2/4分,我们建立了一个新的评分系统。根据ROC分析,总分0-4.5被认为是良性结节,4.5-5.5被认为是低风险结节,超过5.5被认为是恶性结节。与美国放射学会(ACR)-TI-RADS相比,该评分系统在区分良性和恶性结节方面表现更好(P分别为0.001和0.018)。

结论

本研究建立的基于超声特征的评分系统可更有效地用于甲状腺结节的风险分层,对区分良性和恶性结节具有更高的敏感性和特异性。

相似文献

1
A new scoring system for risk stratification of thyroid tumors.一种用于甲状腺肿瘤风险分层的新评分系统。
BMC Med Imaging. 2025 Apr 10;25(1):114. doi: 10.1186/s12880-025-01633-0.
2
Diagnostic efficacy of CEUS TI-RADS classification for benign and malignant thyroid nodules.CEUS TI-RADS分类对甲状腺良恶性结节的诊断效能
Clin Hemorheol Microcirc. 2025;89(1):27-41. doi: 10.3233/CH-232080.
3
Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study.超声造影及TI-RADS分类对甲状腺良恶性肿瘤的临床诊断价值:一项队列对比研究。
Medicine (Baltimore). 2019 Jan;98(4):e14051. doi: 10.1097/MD.0000000000014051.
4
Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.美国放射学院甲状腺影像报告和数据系统(ACR TI-RADS)评分较高是否预示恶性风险增加?评估甲状腺结节时 ACR TI-RADS 与细针穿刺细胞学的相关性研究。
Cancer Cytopathol. 2020 Jul;128(7):470-481. doi: 10.1002/cncy.22254. Epub 2020 Feb 20.
5
Qualitative analysis of contrast-enhanced ultrasound in the diagnosis of small, TR3-5 benign and malignant thyroid nodules measuring ≤1 cm.对比增强超声在诊断直径≤1cm 的 TR3-5 级小良性和恶性甲状腺结节中的定性分析。
Br J Radiol. 2020 Jul;93(1111):20190923. doi: 10.1259/bjr.20190923. Epub 2020 Apr 9.
6
Accuracy of ultrasound in predicting thyroid malignancy: a comparative analysis of the ACR TI-RADS and ATA risk stratification systems.超声在预测甲状腺恶性肿瘤中的准确性:ACR TI-RADS 和 ATA 风险分层系统的比较分析。
Arch Endocrinol Metab. 2024 Apr 26;68:e230245. doi: 10.20945/2359-4292-2023-0245. eCollection 2024.
7
Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System for Thyroid Nodule Malignancy Risk Stratification in a Pediatric Population.评估美国放射学院甲状腺影像报告和数据系统在儿科人群中甲状腺结节恶性风险分层的应用。
AJR Am J Roentgenol. 2019 Jan;212(1):188-194. doi: 10.2214/AJR.18.20099. Epub 2018 Nov 7.
8
Comparative evaluation of shear wave elastography elasticity values in thyroid nodules with cytology results and TI-RADS scoring in differentiation of benign-malignant nodules.对比分析超声弹性成像杨氏模量值在甲状腺结节良恶性鉴别诊断中的价值与细胞学结果和 TI-RADS 评分的相关性。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2609-2617. doi: 10.1007/s00405-024-08516-0. Epub 2024 Mar 10.
9
Benign thyroid nodules classified as ACR TI-RADS 4 or 5: Imaging and histological features.良性甲状腺结节分类为 ACR TI-RADS 4 或 5:影像学和组织学特征。
Eur J Radiol. 2024 Jun;175:111261. doi: 10.1016/j.ejrad.2023.111261. Epub 2023 Dec 14.
10
The diagnostic value of ultrasound on different-sized thyroid nodules based on ACR TI-RADS.基于 ACR TI-RADS 对不同大小甲状腺结节的超声诊断价值。
Endocrine. 2023 Dec;82(3):569-579. doi: 10.1007/s12020-023-03438-z. Epub 2023 Sep 1.

本文引用的文献

1
Comparison of ultrasound findings of papillary thyroid carcinoma subtypes based on the 2022 WHO classification of thyroid neoplasms.基于 2022 年版甲状腺肿瘤 WHO 分类的甲状腺乳头状癌各亚型超声表现比较。
Front Endocrinol (Lausanne). 2024 Aug 14;15:1434787. doi: 10.3389/fendo.2024.1434787. eCollection 2024.
2
Lymph node imaging for thyroid cancer.甲状腺癌的淋巴结影像学检查。
Clin Endocrinol (Oxf). 2024 Jan;100(1):96-101. doi: 10.1111/cen.14993. Epub 2023 Nov 27.
3
US Risk Stratification System for Follicular Thyroid Neoplasms.
美国滤泡性甲状腺肿瘤风险分层系统。
Radiology. 2023 Nov;309(2):e230949. doi: 10.1148/radiol.230949.
4
Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors.NIFT-P 及其他滤泡型甲状腺肿瘤的超声特征与危险分层系统。
Eur J Endocrinol. 2023 Aug 2;189(2):175-182. doi: 10.1093/ejendo/lvad095.
5
Diagnostic performance of the EU TI-RADS and ACR TI-RADS scoring systems in predicting thyroid malignancy.EU TI-RADS 和 ACR TI-RADS 评分系统在预测甲状腺恶性肿瘤中的诊断性能。
Endocrinol Diabetes Metab. 2023 Jul;6(4):e434. doi: 10.1002/edm2.434. Epub 2023 Jun 16.
6
Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.低危分化型甲状腺癌的当前争议:在过度诊断时代减少过度治疗。
J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. doi: 10.1210/clinem/dgac646.
7
Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS.简化版 TI-RADS 对甲状腺恶性结节的诊断性能:与 2017 年 ACR-TI-RADS 和 2020 年 C-TI-RADS 的比较。
Cancer Imaging. 2022 Aug 17;22(1):41. doi: 10.1186/s40644-022-00478-y.
8
The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules.CDFI 和 SMI 联合血清标志物在鉴别甲状腺良恶性结节中的应用价值。
Clin Transl Oncol. 2022 Nov;24(11):2200-2209. doi: 10.1007/s12094-022-02880-1. Epub 2022 Jul 6.
9
Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US.美国低危甲状腺乳头状癌过度诊断和过度治疗的医生观点。
JAMA Netw Open. 2022 Apr 1;5(4):e228722. doi: 10.1001/jamanetworkopen.2022.8722.
10
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.